The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 5,881 followers.

New Research: The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway https://t.co/NA08V3RWlz #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.